Cost-Minimization Analysis of Cefoperazone/Sulbactam Sodium vs. Moxifloxacin in the Treatment of Community Acquired Pneumonia
- VernacularTitle:莫西沙星与头孢哌酮/舒巴坦钠治疗社区获得性肺炎的最小成本分析
- Author:
Jianguo XU
;
Hua ZHU
;
Zhenghua JIANG
- Publication Type:Journal Article
- Keywords:
Community acquired pneumonia;
Cefoperazone/sulbactam sodium;
Moxifloxacin;
Cost-minimization analysis
- From:
China Pharmacy
2007;0(32):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05),respectively.The average cost was 1 314.8 yuan in Group A versus 3 306.5 yuan in Group B(P
